Trial of next-gen weight-loss drug retatrutide brings it one step closer to FDA approval
2026-05-21
·
via Scientific American
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。